http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101350824-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101350824-B1 |
| titleOfInvention | Lipase-specific lipid-peptide substrate library and pharmaceutical composition for the treatment and prevention of diseases related to obesity and lipid metabolism disorders containing lipase inhibitor as an active ingredient |
| abstract | The present invention provides a pharmaceutical composition for the treatment and prevention of obesity and lipid metabolism abnormality-related diseases comprising a lipid-peptide library that is a specific substrate for lipase and a specific inhibitor for lipase synthesized using the same as an active ingredient, and The present invention relates to a health food or a food additive, and more particularly, to the first, second and third generation lipid-peptide libraries of the present invention, specifically bind to and inhibit specific lipases, and thus synthesized lipase inhibitors. Phosphorus sp-X 1 X 2 , Butyl-sp-X 1 X 2 ether and Heptyl-sp-X 1 X 2 ether inhibit specific lipases and maintain high specificity, thereby treating diseases related to obesity and lipid metabolism It can be usefully used as an active ingredient in prophylactic pharmaceutical compositions and health foods, or food additives. |
| priorityDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 158.